Goodwin advised Seagen on the deal. Nurix Therapeutics, Inc. (Nasdaq: NRIX) announced that it has entered into a multi-year, multi-target strategic collaboration agreement with Seagen Inc....
Seagen and Nurix’s Strategic Collaboration
Sanofi’s Exclusive Collaboration with Seagen
Arnold & Porter advised Sanofi on the deal while Goodwin Procter represented Seagen. Sanofi announced its exclusive collaboration with Nasdaq-listed biotech Seagen Inc. to design, develop and...